Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Available in 500mg lyophilized vials
Supplied for in-vitro laboratory research only, not for human or veterinary use
B., Cairns, B
Discussion The results of this population based cohort study, designed to emulate a randomised controlled trial, suggest that the combined use of GLP-1 receptor agonists and SGLT-2 inhibitors is associated with a reduced risk of major adverse cardiovascular events and serious renal events, compared with using either drug class alone
Dereeper A, Audic S, Claverie JM, Blanc G
The most recent consensus algorithm released by the ADA/EASD lists GLP-1 analogues as a treatment option for consideration as a Tier 2 agent, or less well-validated therapy, in T2DM patients ( FIGURE 1 )
US$ 20.26
01585-5/asset/19c5e1a6-3ebc-453e-87c3-a11a7b2d6a64/main.assets/gr1.gif)
US$ 28.32
US$ 26.15
US$ 22.50
US$ 25.72
US$ 26.38
